CD34 and acute promyelocytic leukemia: We evaluated EGFR and the non-receptor tyrosine kinase SYK [a potential off-target of EGFR inhibitors (24)] protein levels in bone marrow (BM) cells obtained from 21 patients diagnosed with APL and a pool of BM-derived CD34+ cells isolated from six healthy subjects (controls).